Comparison of Qigong and Otago in Patient With Diabetic Neuropathy
4. mai 2026 oppdatert av: Riphah International University
Comparison of Qigong and Otago on Agility, Balance, Gait, and Quality of Life in Patients With Diabetic Neuropathy
This study seeks to compare these two interventions to better understand their impact on key health outcomes in patients affected by diabetic neuropathy, providing valuable insights for clinicians and healthcare providers managing this challenging condition
Studieoversikt
Status
Har ikke rekruttert ennå
Forhold
Intervensjon / Behandling
Studietype
Intervensjonell
Registrering (Antatt)
44
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: Muneeb Khan, PhD
- Telefonnummer: +92336799611
- E-post: muneeb.khan@riphah.edu.pk
Studiesteder
-
-
Punjab Province
-
Guiranwala, Punjab Province, Pakistan, 54500
- DHQ Gujranwala
-
Ta kontakt med:
- Javeria Ghazal, MS
- Telefonnummer: +923335154664
-
Hovedetterforsker:
- Junaid Raza, MS
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Nei
Beskrivelse
Inclusion Criteria:
- Physician-diagnosed type 2 diabetes without gender bias, with peripheral neuropathy (defined by Michigan Neuropathy Screening Instrument questionnaire score of 5 or greater)
- Type 2 diabetic peripheral neuropathy patients
- The ability to walk independently for 10 m
- Having score between 46 to 52 (out of a total of 56 points) on the BBS
Exclusion Criteria:
- Fracture of the lower limb within the 6 months before the study (15)
- Diabetic ulcer, infection or partial amputation in feet (15)
- Disease or functional impairment of auditory, vestibular system (16)
- Any other medical conditions that would confound assessment of neuropathy such as malignancy, other neurological or orthopedic impairments (such as stroke, poliomyelitis, rheumatoid arthritis, prosthesis, or severe osteoarthritis), major vascular complications (venous or arterial ulcers), severe retinopathy, or severe nephropathy that causes edema or needs hemodialysis (17)
- Dementia or inability to give consistent information (18)
- History of surgical procedure at the knee, ankle, or hip or indication of surgery throughout the intervention period
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Qigong Balance
|
Quigong Balance Exercises 3 times per week for 60 minutes per session Open the Flow: Focus on fluid arm movements to enhance relaxation and improve circulation. Shaking Exercise: A full-body shake to release tension and promote energy flow. Lifting the Ball: Alternating arm movements simulating lifting a ball to improve upper body strength and coordination. Playing with Water: Slow, flowing movements that enhance balance and mindfulness. Weight Shifting and Balance Exercises: Stand with feet hip-width apart, shifting weight slowly from one leg to the other, holding each position for 10-15 seconds to engage stabilizing muscles in the legs and improve proprioception. Leg Lifts and Extensions: Perform controlled leg lifts (front, side, and back) to strengthen the quadriceps, hamstrings, and hip abductors. |
|
Aktiv komparator: Otago Balance
|
Otago (Strengthening) Balance: Sit-to-stand exercises: to improve leg strength. Heel raises: to enhance calf strength. Toe stands: for improving foot stability. Balance Training: Single-leg stands: to enhance balance. Tandem walking: along a straight line. Side leg raises: to strengthen hip muscles 3 times per week for 60 minutes per session |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Agility T-Test
Tidsramme: 12th week
|
The Agility T-Test is a performance-based assessment that measures an individual's agility and ability to change direction quickly.
It involves a sequence where the participant runs to a designated point, makes sharp turns around markers in a T-shaped layout, and returns to the starting position.
|
12th week
|
|
Berg Balance Scale
Tidsramme: 12th week
|
is the gold standard test for static and dynamic balance abilities.
The BBS is used to measure ability to maintain balance while doing functional task search as reach, standing position and transferences.
It is a valid instrument used for the evaluation of effectiveness of interventions with quantitative description of function in clinical practice as well as research.
It consists of 14 items including simple balance tasks from everyday life.
|
12th week
|
|
Functional Reach Test
Tidsramme: 12th week
|
FRT is a single item test for dynamic balance and acts as a quick screen for balance problems in older adults.
The distance between the lengths of an outstretched arm in a maximal forward reach, while maintaining a fixed base of support is measured.
A score of 6 inches or less indicates a significant increased risk for falls.
A score between 6-10 inches indicates a moderate risk for falls.
the Functional Reach Test (FRT) demonstrates an ICC of approximately 0.85 to 0.94
|
12th week
|
|
Gait Speed Test
Tidsramme: 12th week
|
The Gait Speed Test measures the time it takes for an individual to walk a specific distance, usually 10 meters, at their usual pace.
It has demonstrated strong validity and reliability, with an Intra class Correlation Coefficient (ICC) often exceeding 0.90
|
12th week
|
|
10-Meter Walk Test
Tidsramme: 12th week
|
The 10-Meter Walk Test involves timing a participant as they walk a distance of 10 meters at their comfortable pace.
It assesses gait speed, which is an important indicator of mobility and overall functional ability.
|
12th week
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Hovedetterforsker: Javeria Ghazal, MS, Riphah International University
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Antatt)
15. mai 2026
Primær fullføring (Antatt)
15. august 2026
Studiet fullført (Antatt)
30. august 2026
Datoer for studieregistrering
Først innsendt
23. februar 2026
Først innsendt som oppfylte QC-kriteriene
4. mai 2026
Først lagt ut (Faktiske)
8. mai 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
8. mai 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
4. mai 2026
Sist bekreftet
1. mai 2026
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- REC/RCR &AHS/24/0297
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .